(GLRE) Greenlight Capital Re - Overview
Stock: Reinsurance, Property, Casualty, Specialty
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 24.1% |
| Relative Tail Risk | -2.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -6.68 |
| Character TTM | |
|---|---|
| Beta | 0.393 |
| Beta Downside | 0.369 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.80% |
| CAGR/Max DD | 0.59 |
Description: GLRE Greenlight Capital Re December 27, 2025
Greenlight Capital Re Ltd (NASDAQ:GLRE) is a Cayman-incorporated, globally active property and casualty reinsurer. Through its subsidiaries it underwrites a broad spectrum of reinsurance coverages-including automobile liability, personal and commercial property lines; general liability, umbrella, multiline casualty, workers’ compensation; as well as niche exposures such as cyber, aviation, political risk and terrorism-primarily via reinsurance brokers.
Key industry metrics that shape GLRE’s outlook include the combined ratio (the sum of loss and expense ratios) for the global P&C reinsurance market, which has hovered around 95-100% in 2023, indicating modest underwriting profitability. The firm’s capital adequacy is often measured by the Risk-Based Capital (RBC) ratio; recent filings suggest GLRE maintains an RBC well above the regulatory minimum, providing a buffer against catastrophe losses. Additionally, the sector’s exposure to climate-related events and the pace of inflation in loss reserves are critical drivers of earnings volatility.
For a deeper, data-driven dive into GLRE’s valuation assumptions and scenario analysis, you might find ValueRay’s analytical toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -1.87m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.34 > 1.0 |
| NWC/Revenue: 80.57% < 20% (prev 76.68%; Δ 3.89% < -1%) |
| CFO/TA 0.07 > 3% & CFO 139.5m > Net Income -1.87m |
| Current Ratio: 5.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.8m) vs 12m ago -3.02% < -2% |
| Gross Margin: 6.28% > 18% (prev 0.15%; Δ 612.8% > 0.5%) |
| Asset Turnover: 31.66% > 50% (prev 33.04%; Δ -1.38% > 0%) |
| Interest Coverage Ratio: 3.16 > 6 (EBITDA TTM 4.98m / Interest Expense TTM 5.62m) |
Altman Z'' 2.07
| A: 0.25 (Total Current Assets 655.2m - Total Current Liabilities 127.8m) / Total Assets 2.13b |
| B: 0.08 (Retained Earnings 176.4m / Total Assets 2.13b) |
| C: 0.01 (EBIT TTM 17.8m / Avg Total Assets 2.07b) |
| D: 0.12 (Book Value of Equity 176.4m / Total Liabilities 1.48b) |
| Altman-Z'' Score: 2.07 = BBB |
Beneish M -1.12
| DSRI: 1.05 (Receivables 814.5m/784.7m, Revenue 654.6m/661.3m) |
| GMI: 2.42 (GM 6.28% / 15.19%) |
| AQI: 2.10 (AQ_t 0.69 / AQ_t-1 0.33) |
| SGI: 0.99 (Revenue 654.6m / 661.3m) |
| TATA: -0.07 (NI -1.87m - CFO 139.5m) / TA 2.13b) |
| Beneish M-Score: -1.12 (Cap -4..+1) = D |
What is the price of GLRE shares?
Over the past week, the price has changed by +1.23%, over one month by -0.07%, over three months by +10.55% and over the past year by +1.59%.
Is GLRE a buy, sell or hold?
What are the forecasts/targets for the GLRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1 | -92.9% |
| Analysts Target Price | 1 | -92.9% |
| ValueRay Target Price | 15.4 | 9.3% |
GLRE Fundamental Data Overview February 05, 2026
P/B = 0.7258
P/EG = 2.38
Revenue TTM = 654.6m USD
EBIT TTM = 17.8m USD
EBITDA TTM = 4.98m USD
Long Term Debt = 34.7m USD (from longTermDebt, last quarter)
Short Term Debt = 686.0k USD (from shortTermDebt, last fiscal year)
Debt = 60.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -655.2m USD (from netDebt column, last quarter)
Enterprise Value = -115.4m USD (479.1m + Debt 60.7m - CCE 655.2m)
Interest Coverage Ratio = 3.16 (Ebit TTM 17.8m / Interest Expense TTM 5.62m)
EV/FCF = -0.83x (Enterprise Value -115.4m / FCF TTM 139.5m)
FCF Yield = -120.9% (FCF TTM 139.5m / Enterprise Value -115.4m)
FCF Margin = 21.31% (FCF TTM 139.5m / Revenue TTM 654.6m)
Net Margin = -0.29% (Net Income TTM -1.87m / Revenue TTM 654.6m)
Gross Margin = 6.28% ((Revenue TTM 654.6m - Cost of Revenue TTM 613.5m) / Revenue TTM)
Gross Margin QoQ = 15.53% (prev 17.63%)
Tobins Q-Ratio = -0.05 (set to none) (Enterprise Value -115.4m / Total Assets 2.13b)
Interest Expense / Debt = 2.51% (Interest Expense 1.52m / Debt 60.7m)
Taxrate = 1.72% (749.0k / 43.6m)
NOPAT = 17.5m (EBIT 17.8m * (1 - 1.72%))
Current Ratio = 5.13 (Total Current Assets 655.2m / Total Current Liabilities 127.8m)
Debt / Equity = 0.09 (Debt 60.7m / totalStockholderEquity, last quarter 658.9m)
Debt / EBITDA = -131.5 (out of range, set to none) (Net Debt -655.2m / EBITDA 4.98m)
Debt / FCF = -4.70 (Net Debt -655.2m / FCF TTM 139.5m)
Total Stockholder Equity = 656.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.09% (Net Income -1.87m / Total Assets 2.13b)
RoE = -0.28% (Net Income TTM -1.87m / Total Stockholder Equity 656.2m)
RoCE = 2.57% (EBIT 17.8m / Capital Employed (Equity 656.2m + L.T.Debt 34.7m))
RoIC = 2.46% (NOPAT 17.5m / Invested Capital 709.8m)
WACC = 6.81% (E(479.1m)/V(539.9m) * Re(7.36%) + D(60.7m)/V(539.9m) * Rd(2.51%) * (1-Tc(0.02)))
Discount Rate = 7.36% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.26%
[DCF Debug] Terminal Value 75.99% ; FCFF base≈125.4m ; Y1≈82.3m ; Y5≈37.5m
Fair Price DCF = 46.65 (EV 935.6m - Net Debt -655.2m = Equity 1.59b / Shares 34.1m; r=6.81% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -9.23 | EPS CAGR: -18.81% | SUE: -0.53 | # QB: 0
Revenue Correlation: 68.89 | Revenue CAGR: 3.30% | SUE: 0.82 | # QB: 0